Madam Speaker, I want to thank my colleague for bringing this motion forward and raising a very important issue for Canadians. Many Canadians' access to drugs is already compromised. We currently have a situation in which some drugs in Canada were not protected under price regulation as they were more than 25 years old. Some of these drugs have now risen in price from $48 a month, let us say, to thousands of dollars a month. This is a very important issue for Canadians.
My hon. colleague spoke about price and supply. I wonder if he could comment specifically on the fact that we must continue to have drugs accessible by and available to Canadians and about the concern many of us have felt around the lack of transparency that Health Canada has when it considers any of this information. We have been calling on Health Canada to be much more transparent and open about its process.
This issue around Internet pharmacies is really a good example of the fact that we cannot access the kind of information that is required for us to be able to consider it in a reasonable way. This is certainly one of the reasons why many members of the health committee called on the minister to not do anything more about Internet pharmacies until we hear from Health Canada, and now we urgently need this response due to legislation in the United States.